Covid-19 put spotlight on vaccines, diagnostics: Mazumdar-Shaw
This pandemic has put vaccine development into the spotlight, Biocon chairperson and managing director Kiran Mazumdar-Shaw tells Fortune India. The segment has seen a lot of action of late after "languishing for many, many decades". The resurgence of interest and new technologies bring a refreshing change to vaccine development, and that is a huge opportunity for the biotech field, says Mazumdar-Shaw.
Kiran Mazumdar-Shaw Biocon Biotech Covid vaccine vaccine development covid test vaccines kiran mazumdar-shaw interview
Leave a Comment
Your email address will not be published. Required field are marked*